EP3564378
ÓNÆMISVALDANDI SAMSETNING
Status:
EP Einkaleyfi ógilt eftir andmæliEP appl. date:
25.5.2012EP published:
1.11.2023EP application number:
19179871.9
EP translation filed:
18.1.2024Grant published:
15.2.2024EPO information:
European Patent Register
Max expiry date:
24.5.2032Expiry date:
24.5.2025
Title in English:
IMMUNOGENIC COMPOSITIONLanguage of the patent:
English
Timeline
Today
25.5.2012EP application
1.11.2023EP Publication
18.1.2024Translation submitted
15.2.2024Registration published
24.5.2025Expires
Owner
Name:
GlaxoSmithKline Biologicals SAAddress:
Rue de l'Institut, 89, 1330 Rixensart, BE
Inventor
Name:
CASTADO, CindyAddress:
1330 Rixensart, BE
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
201161490707 PDate:
27.5.2011Country:
US
Number:
201161490734 PDate:
27.5.2011Country:
US
Number:
201161490716 PDate:
27.5.2011Country:
US
Classification
Categories:
C12N 15/62, C07K 14/33, A61K 39/08, A61K 39/00, C07K 16/12, C12N 15/70
Annual fees
Number
Paid
Expires
Payer
Number: 13
Paid: 19.4.2024
Expires: 24.5.2025
Payer: Árnason Faktor ehf.